116. The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above? 这题是不是要说明 解释为什麽制药和其他行业的专利权不同在发展成本皆高的情况下 那(D)An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. 我看不懂这提的意思 可以解释一下吗 (B)Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. B的意思是说在新药获得专利之後 能够上市之前有10年的临床实验 请问是因为临床实验需要10年 所以使得他的收入晚了10 如果没有延长专利 会有仿冒的产品投入市场 造成损失 是这样吗?????? 但是其他行业勒 都不怕有这样的问题吗 天阿 我越想越糊涂 麻烦一下罗 orz -- 女:老板.我要叫一桶瓦斯 我:小姐.几点了.还在叫瓦斯啊 女:我要洗澡没瓦斯啊.当然要叫瓦斯啊 我:我要打泡还找不到女人咧 女:我有再做.可以算你便宜一点喔.你要不要.我现在可以去你那边 我:.......................... 来吧 --

※ 发信站: 批踢踢实业坊(ptt.cc) ◆ From: 203.73.98.104 ※ 编辑: lovekyoko 来自: 203.73.98.104 (05/29 01:33) ※ 编辑: lovekyoko 来自: 203.73.98.104 (05/29 01:43)